Sucheol Gil

1.1k total citations
30 papers, 854 citations indexed

About

Sucheol Gil is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Sucheol Gil has authored 30 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Genetics and 5 papers in Infectious Diseases. Recurrent topics in Sucheol Gil's work include Virus-based gene therapy research (16 papers), CRISPR and Genetic Engineering (12 papers) and RNA Interference and Gene Delivery (6 papers). Sucheol Gil is often cited by papers focused on Virus-based gene therapy research (16 papers), CRISPR and Genetic Engineering (12 papers) and RNA Interference and Gene Delivery (6 papers). Sucheol Gil collaborates with scholars based in United States, Greece and Germany. Sucheol Gil's co-authors include André Lieber, Richard J. Lamont, Chang Li, Hongjie Wang, Aphrodite Georgakopoulou, Evangelia Yannaki, Donald R. Demuth, Burton Rosan, Thalia Papayannopoulou and R. David Hawkins and has published in prestigious journals such as Blood, Journal of Virology and Scientific Reports.

In The Last Decade

Sucheol Gil

30 papers receiving 844 citations

Peers

Sucheol Gil
Jacob S. Leiby United States
David Stein United States
Michael E. Miller United States
Minjun Yu China
Thomas E. Bramanti United States
Mark Payne United Kingdom
Sucheol Gil
Citations per year, relative to Sucheol Gil Sucheol Gil (= 1×) peers Yuichiro Kikuchi

Countries citing papers authored by Sucheol Gil

Since Specialization
Citations

This map shows the geographic impact of Sucheol Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sucheol Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sucheol Gil more than expected).

Fields of papers citing papers by Sucheol Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sucheol Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sucheol Gil. The network helps show where Sucheol Gil may publish in the future.

Co-authorship network of co-authors of Sucheol Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Sucheol Gil. A scholar is included among the top collaborators of Sucheol Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sucheol Gil. Sucheol Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chang, Aphrodite Georgakopoulou, Sucheol Gil, et al.. (2024). Introducing a hemoglobin G-Makassar variant in HSCs by in vivo base editing treats sickle cell disease in mice. Molecular Therapy. 32(12). 4353–4371. 8 indexed citations
2.
Li, Chang, Aphrodite Georgakopoulou, Gregory A. Newby, et al.. (2023). In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model. Blood. 141(17). 2085–2099. 51 indexed citations
3.
Li, Chang, Hongjie Wang, Sucheol Gil, et al.. (2023). Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIV. Molecular Therapy. 31(4). 1059–1073. 3 indexed citations
4.
Wang, Hongjie, Aphrodite Georgakopoulou, Wenli Zhang, et al.. (2023). HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells. Molecular Therapy — Methods & Clinical Development. 29. 213–226. 13 indexed citations
5.
Li, Chang, Aphrodite Georgakopoulou, Gregory A. Newby, et al.. (2022). In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies. JCI Insight. 7(19). 24 indexed citations
6.
Wang, Hongjie, Chang Li, Tien-Ying Hsiang, et al.. (2022). In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor. Human Gene Therapy. 33(7-8). 389–403. 7 indexed citations
7.
Kim, Jiho, Chang Li, Hongjie Wang, et al.. (2022). Translational development of a tumor junction opening technology. Scientific Reports. 12(1). 7753–7753. 5 indexed citations
8.
Wang, Hongjie, Sucheol Gil, Audrey Baldessari, et al.. (2021). Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors. Molecular Therapy — Methods & Clinical Development. 24. 127–141. 33 indexed citations
9.
Wang, Hongjie, Aphrodite Georgakopoulou, Chang Li, et al.. (2020). Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements. JCI Insight. 5(16). 23 indexed citations
10.
Li, Chang, Hongjie Wang, Aphrodite Georgakopoulou, et al.. (2020). In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model. Molecular Therapy. 29(2). 822–837. 50 indexed citations
11.
Li, Chang, Arpit Mishra, Sucheol Gil, et al.. (2019). Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors. Molecular Therapy. 27(12). 2195–2212. 33 indexed citations
12.
Li, Chang, Nikoletta Psatha, Sucheol Gil, et al.. (2018). HDAd5/35++ Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells. Molecular Therapy — Methods & Clinical Development. 9. 390–401. 61 indexed citations
13.
Hübner, Jens-Martin, Peter G. Beidler, Sucheol Gil, et al.. (2017). Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy. Journal of Virology. 91(6). 19 indexed citations
14.
Gil, Sucheol, et al.. (2015). Genotype-specific regulation of oral innate immunity by T2R38 taste receptor. Molecular Immunology. 68(2). 663–670. 36 indexed citations
15.
Grazioli, Serge, Sucheol Gil, Dowon An, et al.. (2015). CYR61 (CCN1) overexpression induces lung injury in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 308(8). L759–L765. 32 indexed citations
16.
Gil, Sucheol, et al.. (2012). Doxycycline impairs neutrophil migration to the airspaces of the lung in mice exposed to intratracheal lipopolysaccharide. Journal of Inflammation. 9(1). 31–31. 27 indexed citations
17.
Gil, Sucheol, William A. Altemeier, Sean E. Gill, et al.. (2012). Fas-deficient mice have impaired alveolar neutrophil recruitment and decreased expression of anti-KC autoantibody:KC complexes in a model of acute lung injury. Respiratory Research. 13(1). 91–91. 6 indexed citations
18.
Lamont, Richard J., Sucheol Gil, Donald R. Demuth, Daniel Malamud, & Burton Rosan. (1994). Molecules of Streptococcus gordonii that bind to Porphyromonas gingivalis. Microbiology. 140(4). 867–872. 37 indexed citations
19.
Lamont, Richard J., et al.. (1994). Identification of a molecule of Porphyromonas gingivalis that binds to Streptococcus gordonii. Microbial Pathogenesis. 17(5). 355–360. 22 indexed citations
20.
Lamont, Richard J., et al.. (1993). Involvement of Porphyromonas gingivalis fimbriae in adherence to Streptococcus gordonii. Oral Microbiology and Immunology. 8(5). 272–276. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026